News

Astrazeneca: Q1 Earnings Snapshot
On a per-share basis, the Cambridge, Britain-based company said it had profit of 93 cents. Earnings, adjusted for non-recurring costs, came to $1.24 per share. The results topped Wall Street ...
AstraZeneca's Q1 profit rises on strong sales; outlook reaffirmed
British pharmaceutical giant AstraZeneca reported a rise in first-quarter profit on Tuesday, driven by strong sales growth in ...
AstraZeneca to keep 2025 forecast if US pharmaceutical tariffs in line with other sectors
The chief executive of AstraZeneca said on Tuesday that the drugmaker will maintain its 2025 sales guidance even if the U.S.
AstraZeneca has built resilient supply chains in the U.S. and China for years, doesn't expect much tariff impact, CEO says
AstraZeneca CEO Pascal Soriot discusses earnings, the potential trade tariff impact on the business and the outlook for the ...
AstraZeneca says may face further import tax fine from China
AstraZeneca on Tuesday said it may face a fine of up to $8 million over suspected unpaid import taxes in China as the ...
AstraZeneca faces fresh China import tax fine of up to $8 million
AstraZeneca may face a fine of up to $8 million in China over suspected unpaid taxes related to the import of its breast ...
AstraZeneca advances Monday, outperforms market
AstraZeneca PLC closed 21.38% short of its 52-week high of £133.88, which the company achieved on September 3rd.
SOPHiA GENETICS Announces Expanded Collaboration with AstraZeneca to Accelerate Liquid Biopsy Testing Globally from AACR
SOPHiA GENETICS (Nasdaq: SOPH), a cloud-native healthcare technology company and global leader in data-driven medicine, today ...